Mechanistic Aspects of Biphenyl Urea-Based Analogues in Triple-Negative Breast Cancer Cell Lines-Reference-Cited by-同舟云学术

Mechanistic Aspects of Biphenyl Urea-Based Analogues in Triple-Negative Breast Cancer Cell Lines

Published:2023-12-15 Issue:1 Volume:7 Page:120-136
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Bandy Rayna¹,Shahi Sadisna¹,Quagraine Naana¹,Shahbazi Nia Siavash¹,Howlader Md Sariful Islam¹,Srivenugopal Kalkunte¹,Stephan Clifford²³,Das Hiranmoy¹,Mikelis Constantinos M.⁴^ORCID,German Nadezhda A.¹⁵^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas 79430, United States

2. Institute of Biosciences and Technology, Texas A&M University, Houston, Texas 79106, United States

3. Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Houston, Texas 77030, United States

4. Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras 26504, Greece

5. Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, Texas 79430, United States

Funder

Cancer Prevention and Research Institute of Texas

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.3c00193

Reference42 articles.

1. Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer

2. Triple negative breast cancer - prognostic factors and survival

3. Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review

4. Recent advances in therapeutic strategies for triple-negative breast cancer

5. Recent progress in small molecule agents for the targeted therapy of triple-negative breast cancer